news
Heroin vaccine could tackle opioid addiction
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
List view / Grid view
Drug delivery
product
Interview: Why is Data Integrity at the heart of the industry
How are you addressing risk management and data integrity...
article
Issue #6 2017 – Digital Version
This issue celebrates European Pharmaceutical Review's 21st birthday through 21 interviews with leading lights from across the pharmaceutical industry...
whitepaper
Application Note: A new crystallinity gauge: Real-time quantification and monitoring of crystallinity in pharmaceuticals
The measurement and quantification of crystallinity in pharmaceuticals is of vital importance, as this has a direct influence on the solubility and stability of the final drug product, affecting both efficacy and expiration...
whitepaper
Whitepaper: Do you know what’s going in? Analysing tablets by NIR spectroscopy
Drug analysis needs to be cost effective without compromising on accuracy...
whitepaper
Application Note: Elemental Impurities
Metallic contamination in drug products, referred to as elemental impurities, may arise from several sources...
whitepaper
Whitepaper: How an integrated development platform can meet the needs of both analytical development and QC teams
This whitepaper explains how an Integrated Development Platform can meet the needs of both analytical development and QC...
news
Niclosamide could lead the fight against Parkinson’s disease
Drug molecule in tapeworm medicine activates protein implicated in the development of Parkinson's disease...
news
Abatacept improves survival in patients with acute GvHD
A drug used to treat rheumatoid arthritis improves survival after hematopoietic stem cell transplant...
article
Meeting access challenges with adaptive trial designs
With access challenges even after successful but costly development programmes, the industry is under pressure to speed up the clinical development process and produce more for less. Adaptive trial designs, more collaborative working and data sharing could provide a solution in the area of cancer immunotherapy, says Jacqueline Karmel, principal…
news
FDA approves first once-monthly buprenorphine injection for OUD
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder...
news
A risk factor for drug-induced skin disease identified
Researchers have identified a type of human leukocyte antigen (HLA) that is associated with the skin disease bullous pemphigoid (BP) in diabetic patients administered with DPP-4 inhibitory drugs.
news
Gene-based Zika vaccine is safe and immunogenic in healthy adults
Results from two Phase 1 clinical trials show an experimental Zika vaccine is safe and induces an immune response in healthy adults.
whitepaper
Whitepaper: Extractables and leachables testing – A risk based approach
Pharmaceutical products are in contact with many external components during both manufacture and usage and small amounts of chemicals may leach from these components with a potential health risk to the patient...
news
Synthetic-biological hybrid nanocapsule combats diseased cells
A new drug delivery system could provide a smart technology for the targeted treatment of a variety of serious diseases...
